[1] MAN GS, MOLOGHIANU G. Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life. 2014;7(1):37-41.
[2] KEEN HI, HENSOR EM, WAKEFIELD RJ, et al. Ultrasound assessment of response to intra-articular therapy in osteoarthritis of the knee. Rheumatology (Oxford). 2015;54(8):1385-1391.
[3] DIEPPE P. Developments in osteoarthritis. Rheumatology (Oxford). 2011;50(2):245-247.
[4] ZHANG Y, XU L, NEVITT MC, et al. Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum. 2001;44(9):2065-2071.
[5] NHO SJ, KYMES SM, CALLAGHAN JJ, et al. The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013;21 Suppl 1:S1-6.
[6] GROGAN SP, D'LIMA DD. Joint aging and chondrocyte cell death. Int J Clin Rheumtol. 2010;5(2):199-214.
[7] XING D, XU Y, LIU Q, et al. Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep. 2016;6:24393.
[8] MCALINDON TE, BANNURU RR, SULLIVAN MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388.
[9] ONDRÉSIK M, AZEVEDO MAIA FR, da Silva Morais A, et al. Management of knee osteoarthritis. Current status and future trends. Biotechnol Bioeng. 2017;114(4):717-739.
[10] LOESER RF, ERICKSON EA, LONG DL. Mitogen-activated protein kinases as therapeutic targets in osteoarthritis. Curr Opin Rheumatol. 2008;20(5):581-586.
[11] 高世超,殷海波,刘宏潇,等.MAPK信号通路在骨关节炎发病机制中的研究进展[J].中国骨伤,2014,27(5):441-444.
[12] NARANTSOGT G, MIN A, NAM YH, et al. Activation of MAPK Is Required for ROS Generation and Exocytosis in HMC-1 Cells Induced by Trichomonas vaginalis-Derived Secretory Products. Korean J Parasitol. 2015;53(5):597-603.
[13] 陈蔚东,蒋青,陈东阳,等. p38蛋白激酶抑制剂对大鼠膝骨关节炎的软骨保护作用[J].山东医药,2007,47(10):21-22
[14] BIJLSMA JW, BERENBAUM F, LAFEBER FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115-2126.
[15] HENROTIN Y, MARTY M, MOBASHERI A.What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis. Maturitas. 2014;78(3):184-187.
[16] 王胜民,刘毅,刘波,等.金骨莲胶囊对兔膝骨关节炎软骨保护作用的研究[J].重庆医学,2016,45(26):3611-3615.
[17] 王胜民,刘毅,熊华章,等.金铁锁灌胃对兔膝骨关节炎的治疗作用及其机制探讨[J].山东医药,2017,57(31):36-40.
[18] LIN MN, LIU XX, WANG SL, et al. Effect of OA kneepad on apoptosis genes Bcl-2 and p53 expression in articular cartilage cells of experimental knee osteoarthritis. Zhongguo Gu Shang. 2009;22(9): 688-691.
[19] ROMAN-BLAS JA, MEDIERO A, TARDÍO L, et al. The combined therapy with chondroitin sulfate plus glucosamine sulfate or chondroitin sulfate plus glucosamine hydrochloride does not improve joint damage in an experimental model of knee osteoarthritis in rabbits. Eur J Pharmacol. 2017;794:8-14.
[20] BELLIDO M, LUGO L, ROMAN-BLAS JA, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010;12(4):R152.
[21] PELLETIER JP, JOVANOVIC D, FERNANDES JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum. 1998;41(7): 1275-1286.
[22] CALVO E, PALACIOS I, DELGADO E, et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage. 2004;12(11): 878-886.
[23] MURPHY JM, FINK DJ, HUNZIKER EB, et al. Stem cell therapy in a caprine model of osteoarthritis.Arthritis Rheum. 2003;48(12): 3464-3474.
[24] HAYAMI T, PICKARSKI M, ZHUO Y, et al. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone. 2006;38(2):234-243.
[25] 许怀来,徐凡平,黄明华,等.中医外治法治疗膝骨关节炎的研究进展[J].中国中医骨伤科杂志,2018,26(11):85-88.
[26] 曾乐,刘毅,熊华章,等.金骨莲胶囊对兔膝关节骨关节炎保护作用的实验研究[J].中国中医骨伤科杂志,2016,24(7):7-11.
[27] 王胜民,刘毅,刘晓丽,等.金铁锁对膝关节骨性关节炎兔关节软骨的保护作用及其机制[J].山东医药,2016,56(16):27-29,111.
[28] MUSUMECI G, CASTROGIOVANNI P, TROVATO FM, et al. Biomarkers of Chondrocyte Apoptosis and Autophagy in Osteoarthritis. Int J Mol Sci. 2015;16(9):20560-20575.
[29] KARSENTI E, VERNOS I. The mitotic spindle: a self-made machine. Science. 2001;294(5542):543-547.
[30] SHINOURA N, MURAMATSU Y, YOSHIDA Y, et al. Adenovirus- mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glioma cells. Exp Cell Res. 2000;256(2):423-433.
[31] SHARIF M, WHITEHOUSE A, SHARMAN P, et al. Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum. 2004;50(2):507-515.
[32] 陈喜德,魏波,杨柳菁,等.不同病期骨关节炎大鼠关节软骨中caspase-3与细胞凋亡的相关性[J].广东医学, 2018,39(2):181-186.
[33] 马钢,任明姬.骨性关节炎软骨细胞凋亡的研究[J].中国组织化学与细胞化学杂志,2012,21(2):196-200.
[34] 刘恒,刘超,曹永平.软骨细胞线粒体功能异常在关节软骨早期退变中的作用[J].中国矫形外科杂志,2011,19(8):652-654.
[35] KOURTIS A, ADAMOPOULOS PG, PAPALOIS A, et al. Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis. Ann Transl Med. 2018;6(12):243.
[36] BROWN KK, HEITMEYER SA, HOOKFIN EB, et al. P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis. J Inflamm (Lond). 2008;5:22.
[37] KÜHN K, SHIKHMAN AR, LOTZ M. Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis. J Cell Physiol. 2003;197(3):379-387.
[38] HAN J, SUN P. The pathways to tumor suppression via route p38. Trends Biochem Sci. 2007;32(8):364-371.
[39] FAN Z, SÖDER S, OEHLER S, et al. Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol. 2007;171(3):938-946.
[40] SHI J, ZHANG C, YI Z, et al. Explore the variation of MMP3, JNK, p38 MAPKs, and autophagy at the early stage of osteoarthritis. IUBMB Life. 2016;68(4):293-302.
[41] RASHEED Z, AKHTAR N, HAQQI TM. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res Ther. 2010;12(5):R195.
[42] MOREL C, IBARZ G, OIRY C, et al. Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase. J Biol Chem. 2005;280(22):21384-21393.
|